Sumoylation pathway as potential therapeutic targets in cancer

L. Gong, R. Qi, D. W.C. Li

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Sumoylation is a covalent protein posttranslational modification that conjugates the small ubiquitin-like peptide SUMO to substrate. Sumoylation is critically implicated in multiple biological processes, including cell proliferation, differentiation, senescence and apoptosis, etc. Therefore, it is not surprising that dysregulation of sumoylation has been implicated in tumorigenesis and different types of cancer were found to be addicted to functional sumoylation pathway. The potential role for sumoylation as a therapeutic target in caner is emerging. In this review, we summarize current knowledge regarding the involvement of sumoylation in genome stability and DNA damage response. We will further discuss the therapeutic potential of sumoylation as synthetic lethal partner and as a key signaling pathway in cancer stem cells.

Original languageEnglish (US)
Pages (from-to)900-905
Number of pages6
JournalCurrent Molecular Medicine
Issue number10
StatePublished - Dec 1 2016


  • Cancer stem cell
  • DNA damage response
  • Genome stability
  • Sumoylation
  • Synthetic lethality

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Sumoylation pathway as potential therapeutic targets in cancer'. Together they form a unique fingerprint.

Cite this